Verséa Health

Verséa Health is a privately-held, commercial-stage diagnostics and healthcare company headquartered in Austin, Texas, with a listed operational address in Tampa, Florida. The company has built a diversified portfolio across diagnostics, ophthalmics, and discovery platforms, focusing on point-of-care testing, personalized mitochondrial screening, and ophthalmic therapeutics. Led by founders with growth and acquisition experience, Verséa has established a broad network of healthcare provider and retail relationships, holds key intellectual property, and has achieved ISO 9001 certification, positioning it as an integrated provider in the evolving proactive healthcare market.

Diversified platforms across three business units: 1) Point-of-Care, OTC, and lab-based diagnostic solutions; 2) Tear-based POC testing and regenerative therapeutics for ophthalmology; 3) Personalized Mitochondrial Health Screening and cellular metabolism research platforms for drug discovery and personalized medicine.

Verséa competes in the diagnostics space against large, established players like Abbott, Roche, and Quest, as well as numerous niche startups. In ophthalmics, it faces competition from specialized device and pharmaceutical companies. Its mitochondrial health platform operates in a nascent but increasingly competitive field of personalized and metabolic health companies.